Purchase Order 75N95020P00314
Award Date 7/9/20
Potential Completion Date 10/8/20
Potential Value $291K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents, a $496,846.73 firm fixed price delivery order contract for whole genome sequencing kits. The contract, which does not have a set-aside designation, is for the provision of Illumina's sequencing products and services to support the agency's genomics research and diagnostic initiatives. Illumina has...
- The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of goods, for the provision of whole genome sequencing kits. The potential value of the contract is $265,095.63, with a completion date of May 22, 2020. The contract does not have a set-aside designation. Illumina, Inc. is a provider of sequencing and array-based solutions for genetic and genomic analysis, and...
- The Department of Health and Human Services National Institutes of Health (NIH) National Institute of Environmental Health Sciences awarded a $210,784.04 firm fixed-price delivery order contract to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, sample preparation kits, and bioinformatics support. This award is not...
- The Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed price delivery order contract to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $197,834.87 contract provides Illumina's NextSeq 2000 and 1000/2000 sequencing reagents to support life science research and diagnostics. This award is not associated with a set-aside program. Illumina has a history...
- This is a firm fixed-price delivery order awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical instruments. The contract, valued at $149,982.23, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services,...
- This $149,519.97 firm fixed price delivery order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The order is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, and bioinformatics support. The contract does...
- The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $197,925.00 firm fixed price purchase order for an Illumina NextSeq Sequencing System to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents. The purchase order was not set aside for any specific business size or type. The award is intended to support the agency's mission by providing a sequencing platform that can increase data output...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and related products. The contract is for the provision of a NEXTSEQ 1000 SEQUENCING SYSTEM, with a potential value of $142,100.00. The contract does not have a set-aside designation and is expected to be completed by April 14, 2025. Illumina has...
- This federal contract award is for a firm fixed price delivery order issued by the National Institute on Aging (NIA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The $81,793.80 order is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) awarded a $178,500.00 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents, for the purchase of a NextSeq 500 sequencing system. This award supports the NIH's research and diagnostic needs, as Illumina has provided a range of sequencing systems and consumables to HHS, the Centers for Disease Control and Prevention, the Department of...